Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 0.0 | BCD100624C002 | 127 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 0.5 | BCD100624C005 | 106 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 1.0 | BCD100624C009 | 48.3 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 2.0 | BCD100624C013 | - | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 4.0 | BCD100624C017 | 156 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 8.0 | BCD100624C021 | 217 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 12.0 | BCD100624C025 | 103 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 24.0 | BCD100624C029 | 36.1 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 0.0 | BCD100624C001 | 140 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 0.5 | BCD100624C003 | 105 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 1.0 | BCD100624C007 | 50.9 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 2.0 | BCD100624C011 | 119 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 4.0 | BCD100624C015 | 107 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 8.0 | BCD100624C019 | 98.3 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 12.0 | BCD100624C023 | 127 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 24.0 | BCD100624C027 | 80.7 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100624C006 | 96.6 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100624C010 | - | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100624C014 | 159 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100624C018 | 85.6 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100624C022 | 80.4 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100624C026 | 69.5 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100624C030 | 40.2 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 0.5 | BCD100624C004 | 102 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 1.0 | BCD100624C008 | 69 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 2.0 | BCD100624C012 | 156 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 4.0 | BCD100624C016 | - | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 8.0 | BCD100624C020 | 135 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 12.0 | BCD100624C024 | 42.2 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 24.0 | BCD100624C028 | 70.5 | pmol/sample |